The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
4 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $310,870 in first-year total cost, median $77,750.
Most frequent study sections
- Developmental Therapeutics Study Section[DT]2
- Biomedical Imaging Technology B Study Section[BMIT-B]1
- Drug Discovery and Molecular Pharmacology Study Section[DMP]1
Most frequent institutions
- JOHNS HOPKINS UNIVERSITY2
- ROSWELL PARK CANCER INSTITUTE CORP1
- UNIVERSITY OF UTAH1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2015 | Developing a Screen for Novel Therapies with Reprogrammed Pancreatic Cancer Cells1R03CA191621-01 | RESAR, LINDA M S | JOHNS HOPKINS UNIVERSITY, MD | $81,000 | DMP |
| 2015 | Endoenteric Balloon Coils for Improved MR Imaging of the Pancreas and Upper GI Tract1R03CA195453-01 | HADLEY, JOHN ROCK | UNIVERSITY OF UTAH, UT | $74,500 | BMIT |
| 2014 | A novel regimen to target both pancreatic cancer K-ras and antiapoptotic proteins1R03CA182552-01 | LI, FENGZHI | ROSWELL PARK CANCER INSTITUTE CORP, NY | $84,900 | DT |
| 2014 | Developing Nanotechnology to Target HMGA1 in Pancreatic Cancer1R03CA182679-01A1 | RESAR, LINDA M S | JOHNS HOPKINS UNIVERSITY, MD | $70,470 | DT |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.